TCM Biotech International Corp.
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceutica… Read more
Market Cap & Net Worth: TCM Biotech International Corp. (4169)
TCM Biotech International Corp. (TWO:4169) has a market capitalization of $392.63 Million (NT$12.99 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #13756 globally and #450 in its home market, demonstrating a -8.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TCM Biotech International Corp.'s stock price NT$220.00 by its total outstanding shares 59048612 (59.05 Million).
TCM Biotech International Corp. Market Cap History: 2026 to 2026
TCM Biotech International Corp.'s market capitalization history from 2026 to 2026. Data shows growth from $392.63 Million to $392.63 Million (0.00% CAGR).
TCM Biotech International Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TCM Biotech International Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4169 by Market Capitalization
Companies near TCM Biotech International Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to TCM Biotech International Corp. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
TCM Biotech International Corp. Historical Marketcap From 2026 to 2026
Between 2026 and today, TCM Biotech International Corp.'s market cap moved from $392.63 Million to $ 392.63 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$392.63 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of TCM Biotech International Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $392.63 Million USD |
| MoneyControl | $392.63 Million USD |
| MarketWatch | $392.63 Million USD |
| marketcap.company | $392.63 Million USD |
| Reuters | $392.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.